Home › Ovarian Cancer › NCT06036810
Spanish Decision Tool for Ovarian Cancer Maintenance Therapy
Recruiting
Engaging Patients in Decision Making: The Development and Pilot Testing of a Low Literacy Spanish Language Shared Medical Decision Tool for Ovarian Cancer Maintenance Therapy
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Study population: This study will enroll patients and clinical providers. Inclusion criteria: Patients • Eligible patients must be: 1) individuals ≥ 18 years with advanced stage high grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are receiving or have completed platinum-based chemotherapy for ovarian cancer and are potentially eligible to receive maintenance therapy; 2) able to understand, speak or read in Spanish. Exclusion criteria: Patients • Inability or unwillingness to sign informed consent Inclusion criteria: Clinicians • Eligible clinicians will include: 1) MD Anderson gynecologic oncologists and advanced practice providers who practice at the Houston Area Locations (HALs), MD Anderson Cancer Center, or our county safety net hospital, The Harris Health System (LBJ Hospital). Exclusion criteria: Clinicians • Inability or unwillingness to sign informed consent
About the study
To develop a shared decision-making (SDM) tool to help Spanish-speaking patients make decisions about their maintenance therapy
What is being tested
- Shared Medical Decision Tool (other)
- Engaging Patients in Decision Making (behavioral)
- Literacy Spanish Language (behavioral)
Sponsor: M.D. Anderson Cancer Center · Participants: 70 · Started: Aug 31, 2023
Contact the study team
- Larissa Meyer, M D · Phone: (713) 745-0973
Official record on ClinicalTrials.gov — NCT06036810
Locations in the U.S.
| Texas | M D Anderson Cancer Center, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.